Compugen | CGEN - Ebit

Stock Price
700.90
Daily Change
45.10 6.88%
Monthly
8.75%
Yearly
48.21%
Q2 Forecast
636.32

Compugen reported $56.04M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Arca Biopharma USD -34.43M 326K Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
Bio Path USD -488K 4.07M Sep/2025
Brainstorm Cell Therapeutics USD -2.05M 526K Sep/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
Immunic USD -22.81M 756K Jun/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
RedHill Biopharma USD 2.69M 47.97M Jun/2023
TherapeuticsMD USD -1.77M 699K Sep/2023